Search – Page 58 – Indianapolis Business Journal

Home » Search

Articles

2020 CFO of the Year: Cynthia Lucchese

December 11, 2020 | Tom Harton

Cindy Lucchese steers the financial fortunes of Penske Entertainment, the Roger Penske-owned entity she helped create when the racing icon bought the Indianapolis Motor Speedway, the IndyCar series and IMS Productions from the Hulman family in January 2020.

2020 CFO of the Year: Todd Young

December 11, 2020 | Tom Harton

With Todd Young’s guidance, Elanco spun off from Eli Lilly and Co. in March 2019. In the process, Young built a 60-person corporate finance department from scratch.

Indy Beacons: Bruno Schmitz, designer of Indy’s most prominent structure

December 10, 2020 | Richard Gunderman / Special to IBJ

The German architect who designed the Soldiers and Sailors Monument also drew up plans for the three largest war monuments in Germany.

Lilly starting new trial for COVID-19 antibody, potentially widening already red-hot market

December 7, 2020 | John Russell

Lilly said it will enroll up to 500,000 people in its latest study, with at least 5,000 people expected to receive bamlanivimab therapy. The drugmaker is partnering with health insurer UnitedHealth Group to see if the drug will help high-risk people.

Greenfield leaders hopeful city will recover from losing Elanco HQ

December 4, 2020 | Samm Quinn

Elanco Animal Health Inc.’s announcement Friday that it will move its headquarters to Indianapolis came as a surprise to many business leaders in Greenfield. While disappointed, they say they are hopeful the move won’t be a significant blow to the city’s economy.

Combined state, local incentives for Elanco total at least $150M

December 4, 2020 | Lindsey Erdody

The total doesn’t include the value of the land the state will give to Elanco Animal Health for the project. Even so, the combined city and state package is possibly the largest amount of tax breaks ever considered for an economic development deal in Indiana.

No longer sleepy and small, Elanco marks transformation with new HQ

December 4, 2020 | John Russell

CEO Jeff Simmons said the company’s high-profile downtown Indianapolis headquarters will signal a cultural transformation at the company, which for most of its six decades of existence operated as a little-noticed subsidiary of Eli Lilly and Co.

Elanco to build $100 million HQ campus at former GM site downtown

December 4, 2020 | John Russell and Lesley Weidenbener

The state has offered at least $86 million in tax incentives, plus land for the project.

Business leaders say focus must remain on racial inequality for years to come

December 3, 2020 | Lindsey Erdody

During IBJ’s Engage Indiana 2020 virtual event Thursday morning, Eli Lilly & Co. CEO Dave Ricks said he always believed enhancing diversity and inclusion was important, but this year showed him how serious a problem racial injustice is and fueled his motivation to do more to address it.

CVS prepares to administer Lilly antibody drug, as feds buy 650,000 more doses for $812.5M

December 2, 2020 | Bloomberg News and IBJ Staff

CVS has developed a program to provide the treatments in their homes, but it won’t be available—at least initially—in Indianapolis.

EDITORIAL: Lilly seized chance to be leader in global fight against COVID-19

November 27, 2020 | IBJ Staff

While efforts to create a COVID-19 vaccine have garnered the most headlines, Eli Lilly and Co. turned its attention to another critical need—helping those who contract the disease get better.

Experimental drug given to Trump to treat COVID-19 wins FDA clearance

November 21, 2020 | The Washington Post

It is the second drug of this type—called a monoclonal antibody—to be cleared for COVID-19. The FDA authorized Eli Lilly and Co.’s drug on Nov. 9.

Trump makes late-term bid to lower prescription drug costs

November 20, 2020 | Associated Press

In a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether the incoming Biden administration will accept, amend or try to roll them back entirely.

After sputtering start, biosciences institute eager to innovate

November 20, 2020 | John Russell

The not-for-profit launched in 2013 as a way to bridge the gap between research universities and industry in life sciences. But its report card so far is decidedly mixed, and it just hired its third CEO.

As colleges retrench, Marian goes on offensive

November 20, 2020 | Samm Quinn

During a year filled with uncertainty for many industries, including higher education, the small Catholic university is preparing to embark on another ambitious project.

Health experts clash over use of certain drugs for COVID-19

November 20, 2020 | Associated Press

In a separate development, the FDA on Thursday gave emergency authorization to use of another anti-inflammatory drug sold by Eli Lilly, baricitinib, to be used with remdesivir.

Lilly arthritis drug gets FDA emergency use authorization for COVID-19 patients

November 19, 2020 | John Russell

The Indianapolis drugmaker said Thursday evening it was awarded an emergency use authorization for its drug baricitinib to be used in combination with Gilead Sciences’ antiviral drug remdesivir in severely ill, hospitalized patients with COVID-19.

Trump officials promise fair distribution of Lilly’s new COVID-19 antibody drug

November 11, 2020 | The Washington Post

Because of the initial limited supply, the number of doses each state receives will be determined by the number of confirmed cases and hospitalizations in a given week, federal officials said.

Lilly’s COVID-19 treatment expected to be in short supply initially

November 10, 2020 | The Washington Post

The initial scarcity of the drug and the logistical complexities of administering it could mute its immediate impact on the pandemic and raise questions about whether it is being distributed to people in the greatest need.

U.S. allows emergency use of Lilly’s COVID-19 antibody drug

November 9, 2020 | Associated Press

The Food and Drug Administration on Monday cleared the experimental drug from Indianapolis-based Eli Lilly and Co. for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. It’s a one-time treatment given through an IV.

« Previous 1 … 56 57 58 59 60 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'